Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. (Q54409967)

29 May 2018

title

Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. (English)

1 reference

29 May 2018

1 reference

1 reference

3

1 reference

29 May 2018

author name string

Masami Masuda

1

1 reference

29 May 2018

Masato Hasegawa

2

1 reference

29 May 2018

Takayuki Oikawa

4

1 reference

29 May 2018

Motokuni Yonetani

5

1 reference

29 May 2018

Yoshiki Yamaguchi

6

1 reference

29 May 2018

Koichi Kato

7

1 reference

29 May 2018

Shin-Ichi Hisanaga

8

1 reference

29 May 2018

Michel Goedert

9

1 reference

29 May 2018

language of work or name

English

0 references

publication date

4 February 2009

1 reference

29 May 2018

published in

FEBS Letters

1 reference

29 May 2018

volume

583

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

787-791

1 reference

29 May 2018

A century of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Alpha-synuclein and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Prion diseases--close to effective therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Small molecule inhibitors of alpha-synuclein filament assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Cysteine misincorporation in bacterially expressed human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

The fold of alpha-synuclein fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Biochemical characterization of the core structure of alpha-synuclein filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

alpha-Synuclein misfolding: single molecule AFM force spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Conformational equilibria in monomeric alpha-synuclein at the single-molecule level

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.01.037

10.1016/J.FEBSLET.2009.01.037

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

19183551

1 reference

29 May 2018